oral semaglutide weight loss effectiveness 🚨 25 mg delivers double-digit in OASIS-4 (Phase 3 trial) - 50 mg of oral #semaglutide

Such work could open up new therapeutic avenues (AAAS)

It came in the mail as expected, not hiccups at all

If another clinician adds a new medicine, mention metoprolol so interaction risks can be reviewed

To view or add a comment, sign in Genentech Reports the US FDA's Approval of Gazyva (Obinutuzumab) to Treat Lupus Nephritis #genentech #gazyva #obinutuzumab #lupusnephritis #usfda #regulatory #monoclonalantibody #nobility #regency #pii #piii #ro5072759 #rg7159 #r7159 #ga101 To view or add a comment, sign in Potential future royalty income from Metsera/Pfizer* obesity drug candidates As highlighted in our 2025 half-yearly results, IP Group has financial exposure to several of Metseras obesity drug programmes, following its acquisition of our former portfolio company Zihipp Limited in 2023

Early clinical and preclinical data suggest benefits also in rheumatoid arthritis, osteoarthritis, osteoporosis, psoriasis, and hidradenitis suppurativa